Ticker Details
Pliant Therapeutics, Inc.
IPO Date:	June 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$83.58M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.50 | 3.18%
Avg Daily Range (30 D):	$0.04 | 2.98%
Avg Daily Range (90 D):	$0.04 | 2.80%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	.48M
Avg Daily Volume (90 D):	.95M

Trade Size
Avg Trade Size (Sh.):	103
Avg Trade Size (Sh.) (30 D):	222
Avg Trade Size (Sh.) (90 D):	317

Institutional Trades
Total Institutional Trades:	1,077
Avg Institutional Trade:	$1.5M
Avg Institutional Trade (30 D):	$.61M
Avg Institutional Trade (90 D):	$.71M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.58M
Avg Closing Trade (30 D):	$.61M
Avg Closing Trade (90 D):	$.61M
Avg Closing Volume:	102.46K

News

Mar 23, 2025 @ 12:34 PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates ... Source: N/A

Feb 7, 2025 @ 9:58 PM Pliant Therapeutics Provides Update on BEACON-IPF,... Source: N/A

Nov 18, 2024 @ 11:00 PM Pliant Therapeutics Presents Data from its Bexoteg... Source: N/A

Jul 13, 2024 @ 1:35 AM Pliant Therapeutics CBO sells shares worth over $1... Source: Investing.Com

May 7, 2024 @ 3:53 PM These Analysts Revise Their Forecasts On Pliant Th... Source: Avi Kapoor

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.43	$-.38	$-2.43
Diluted EPS	$-2.43	$-.38	$-2.43
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-149.34M	$-23.58M	$-149.34M
Operating Income / Loss	$-156.37M	$-23.58M	$-156.37M
Cost of Revenue
Net Cash Flow	$-25.74M	$-48.29M	$-25.74M
PE Ratio